PRUNUS Therapeutics

Sustainable therapeutics via synthetic biology

[PRUNUS Therapeutics @Prunus_nb]

By nailing down the key biological differences between cancer and normal cells, PRUNUS is pioneering an entirely new way of targeting #Cancer. https://t.co/dduSpQlzpy

[PRUNUS Therapeutics @Prunus_nb]

@H_Nakaminami Urgent need of anti-spheroids

[NatureRevClinOncol @NatRevClinOncol]

New open access Position Paper from the Cancer Research UK and Cancer Therapeutics CRC Australia Metastasis Working Group now live online: 'A framework for the development of effective anti-metastatic agents' - https://t.co/0Or0xlaV5K

[Simona Cristea @simocristea]

The importance of this👇cannot be underscored:

#caner is a unique evolutionary process. tumors are expected to be genetically v distinct.

each tumor = its own world.

Therefore: #scRNAseq analyses of cancer tissue data SHOULD NOT‼️BLINDLY include data integration as 1st step🧵

[PRUNUS Therapeutics @Prunus_nb]

@__ice9 @Maverick2608 https://t.co/AFkW6uEdsA

[PRUNUS Therapeutics @Prunus_nb]

#cancer #immunotherapy https://t.co/srjGeGM9j5

[Tatiana Prowell, MD @tmprowell]

To be truly transformative, a new cancer therapy must be effective, safe, and within reach of every patient who needs it. I challenge any company to develop even one. Let’s see what you’ve got. https://t.co/IslHYxGTzU